Table 3.
The three most consumed PIMs according to the EU(7)-PIM list, Beers 2019, and STOPP v2 criteria
| Position | EU(7)-PIM list | Beers 2019 | STOPP v2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| PIM | n | % PIM | PIM | n | % PIM | PIM | n | % PIM | |
| 1 | Proton pump inhibitors | 362 |
a) 24.7% b) 30.1% (95% CI 27.6–32.9%) |
Proton pump inhibitors | 362 |
a) 19.9% b) 30.1% (95% CI 27.6–32.9%) |
Alprazolam | 121 |
a) 12.3% b) 10.1% (95% CI 8.4–11.9%) |
| 2 | Alprazolam | 121 |
a) 8.3% b) 10.1% (95% CI 8.4–11.9%) |
Furosemide | 181 |
a) 9.9% b) 15.1% (95% CI 13.1–17.2%) |
Tramadol and paracetamol | 94 |
a) 8.8% b) 7.8% (95% CI 6.4–9.5%) |
| 3 | Diazepam | 68 |
a) 4.6% b) 5.7% (95% CI 4.4–7.1%) |
Alprazolam | 121 |
a) 6.6% b) 10.1% (95% CI 8.4–11.9%) |
Lorazepam | 73 |
a) 6.9% b) 6.1% (95% CI 4.8–7.6%) |
CI confidence interval, PIM potentially inappropriate medications
a) percentage of PIMs per tool, b) percentage of PIMs per older adult (n = 1200)